Advertisement
They discovered that a class of metallodrugs currently used in the treatment of other infectious diseases is showing efficacy to potently suppress SARS-CoV-2 replication and relieve viral-associated symptoms in an animal model.
According to Phys.org, The findings provide a new and readily available therapeutic option with high clinical potential for infection with SARS-CoV-2.
Researchers claim that They are metallodrugs, which consist of metal compounds. Generally, metal compounds are used as anti-microbial agents, but their antiviral activities have rarely been explored
Related Articles
Advertisement